Phosphatidylserine binding directly regulates TIM-3 function
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Co-signaling receptors for the T cell receptor (TCR) are important therapeutic targets, with blockade of co-inhibitory receptors such as PD-1 now central in immuno-oncology. Advancing additional therapeutic immune modulation approaches requires understanding ligand regulation of other co-signaling receptors. One poorly understood potential therapeutic target is TIM-3 (T cell immunoglobulin and mucin domain containing-3). Which of TIM-3's several proposed regulatory ligands is/are relevant for signaling is unclear, and different studies have reported TIM-3 as a co-inhibitory or co-stimulatory receptor in T cells. Here, we show that TIM-3 promotes NF-κB signaling and IL-2 secretion following TCR stimulation in Jurkat cells, and that this activity is regulated by binding to phosphatidylserine (PS). TIM-3 signaling is stimulated by PS exposed constitutively in cultured Jurkat cells, and can be blocked by mutating the PS-binding site or by occluding this site with an antibody. We also find that TIM-3 signaling alters CD28 phosphorylation. Our findings clarify the importance of PS as a functional TIM-3 ligand, and may inform the future exploitation of TIM-3 as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. TIM-3 modulates CD28 phosphorylation after αCD3/αCD28 stimulation. Changes in CD28 phosphorylation following TCR activation with αCD3/αCD28 as in Figure 1 were monitored by Western blotting using phospho-specific antibodies. (A) Representative Western blot of pY191 in CD28 for TIM-3+ and parental NF-κB reporter Jurkat cells. Grb2 was used as a loading control as described [44]. Quantification bar graphs indicate mean band intensity ± SD (n = 6 biological repeats). Two-tailed, unpaired Student's t-test was used to determine P-values. (B) Representative Western blot of pY218 in CD28 for TIM-3+ and parental NF-κB reporter cells, with quantitation below the blot. Grb2 was used as a loading control. Bars indicate mean band intensity ± SD for the 5 min time point (seven biological repeats) with P-values determined by two-tailed, unpaired Student's t-test. (C) Parental, TIM-3+, and PD-1-expressing NF-κB reporter Jurkat cells were stimulated for 5 min with αCD3/αCD28 (1 μg/ml each) with- or without the PI3K inhibitor, wortmannin (0.2 μM) to show that PTEN deficiency does not account for the effect of TIM-3 expression on CD28 phosphorylation.](https://figures.cochat.ai/paper-figures/2242905c9d9d4695beac40e2036e32f4/phosphatidylserine-binding-directly-regulates-tim-3-function-figure-2.jpg)


![Figure 5. Mutated TIM-3 variants with impaired PS-binding lose co-stimulatory signaling. (A) Details of the PS-binding site in murine TIM-3 (PDB: 3KAA — blue) overlaid on human TIM-3 (PDB: 6TXZ — red), revealing key interacting residues [34,82]. Inset at the right shows the PS-binding pocket, where short-chain PS is sandwiched by L99/M100 and W41 in mTIM-3 (I96/M97 and F40 in human TIM-3). A calcium ion (gray sphere) also sits in the binding pocket and interacts with the negatively charged PS headgroup. (B) PS binding of wild-type sTIM-3 (solid red curve), sTIM-3F40A (solid magenta curve), and sTIM-3I96A/M97A (dotted magenta curve) were analyzed using SPR by flowing the purified sTIM-3 variants over 20% DOPS/80% DOPC lipid vesicles immobilized on an L1 chip (in the presence of 1 mM CaCl2). Binding curves are representative of at least three independent experiments. Kd values for sTIM-3F40A and sTIM-3I96A/M97A were too high to measure, both appearing to exceed ∼200 μM (although PS binding was detectable). (C) A GFP reporter was used to measure NF-κB transcriptional activity downstream of TCR activation with 1 μg/ml αCD3 plus 0.5 μg/ml αCD28 for 16 h. Representative histogram of NF-κB-driven GFP expression is shown for parental NF-κB GFP reporter cells (black), and those expressing TIM-3WT (solid red curve), TIM-3F40A (solid magenta curve), and TIM-3I96A/M97A (dotted magenta curve) variants. (D) Relative mean GFP fluorescence intensity (MFI), expressed as fold change over parental cells within each experiment, was determined across eight biological replicates for parental NF-κB GFP reporter cells (black) or those expressing TIM-3WT (solid red line, open bar), TIM-3F40A (solid magenta line, open bar and data points), or TIM-3I96A/M97A (dotted magenta line, gray filled bar and data points). Means ± SD are plotted, with P-values determined by two-tailed, unpaired Student's t-tests. (E) ELISA analysis of IL-2 secreted into the cell culture medium by parental NF-κB GFP reporter cells, and those expressing, TIM-3WT (solid red line, open bar), TIM-3F40A (solid magenta line, open bar and data points), or TIM-3I96A/M97A (dotted magenta line, gray filled bar and data points) following stimulation by αCD3/αCD28, as described in (C). Means ± SD are plotted for three biological repeats. P-values comparing TIM-3WT with the mutated TIM-3 variants were determined using two-tailed, unpaired Student's t-tests. (F) Analysis of TNFα secretion into the cell culture medium was performed using a Luminex assay. Cells were stimulated with αCD3/αCD28 (1 μg/ml each) for 16 h. Mean values ± SD are plotted for parental (black line, open bar), TIM-3WT (solid red line, open bar), TIM-3F40A (solid magenta line, open bar and points), and TIM-3I96A/M97A (dotted magenta line, gray filled bar and data points). Two-tailed, unpaired Student's t-tests were used to compare TIM-3WT with mutated TIM-3 variants for three biological repeats. (G) SEE-loaded Raji B cells were used to stimulate NF-κB GFP reporter Jurkat cells to recapitulate the formation of an immunological synapse. IL-2 production following Raji B cell stimulation was determined by ELISA analysis for parental NF-κB GFP reporter cells (solid black line, open bar) and cells expressing TIM-3WT (solid red line, open bar), TIM-3F40A (solid magenta line, open bar and data points), or TIM-3I96A/M97A (dotted magenta line, gray filled bar and data points). Mean ± SD are plotted for three biological repeats, with P-values comparing TIM-3WT with the mutated TIM-3 variants determined using two-tailed, unpaired Student's t-tests.](https://figures.cochat.ai/paper-figures/9f54c045f8054324a3e7431099e31def/phosphatidylserine-binding-directly-regulates-tim-3-function-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another data revealed that the blockade activity of the TIM‐3 or galectin 9 axis is due to the action of galectin 3 by clustering TIM‐3 to inhibit the binding to PS [314].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [314]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114 · cited 1×
“The functional outcome when an antigen engages the T cell receptor (TCR) depends on the activity of a wide range of ‘ co-signaling receptors ’ in T cells [1], which can be stimulatory (like CD28) or inhibitory (like CTLA-4 and PD-1).”
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072 · cited 1×
“Nonetheless, pre-clinical studies have indicated that antibody blockade of TIM-3, in combination with PD-1 blockade, may be a promising therapeutic approach in cancer [9,10].”
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057 · cited 2×
“The fi rst was the lectin family member galectin-9 [26], which has two β -galactoside-binding carbohydrate-recognition domains.”
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Membrane recognition by phospholipid-binding domains
Lemmon, M. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2328 · Cited by 1,419 · cited 1×
“…values are in the same range as those measured for other PS-binding proteins, pleckstrin homology domains and other peripheral membrane proteins [45,61,62], and indeed, for recognition of the prototypical T cell co-receptors CD28 and PD-1 for their respective ligands, CD80/86 [63] and PD-L1 [64].”
Self-citationFourcade, J., Sun, Z., Benallaoua, M., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Kuchroo, V., & Zarour, H. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100637 · Cited by 1,307 · cited 1×
“Nonetheless, pre-clinical studies have indicated that antibody blockade of TIM-3, in combination with PD-1 blockade, may be a promising therapeutic approach in cancer [9,10].”
Identification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180 · cited 2×
“PS was initially suggested as a TIM-3 ligand based on homology between TIM-3 and the known PS receptor TIM-4 [33].”
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization
Yeung, T., Gilbert, G. E., Shi, J., Silvius, J., Kapus, A., & Grinstein, S. (2008) · Science · doi:10.1126/science.1152066 · Cited by 1,107 · cited 1×
“…values are in the same range as those measured for other PS-binding proteins, pleckstrin homology domains and other peripheral membrane proteins [45,61,62], and indeed, for recognition of the prototypical T cell co-receptors CD28 and PD-1 for their respective ligands, CD80/86 [63] and PD-L1 [64].”
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010 · cited 1×
“…adding annexin V elevated TCR-driven NF-κ B signaling independently of TIM-3 expression (Supplementary Figure S5C,D) — likely because of its reported effects on membrane structure [57], which are likely to alter TCR clustering and activity as seen when cholesterol levels are changed [58].”
Cited by
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
Gaikwad, S. R., Agrawal, M. Y., Kaushik, I., Ramachandran, S., & Srivastava, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.014 · Cited by 172
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Sauer, N. J., Janicka, N., Szlasa, W., Skinderowicz, B., Kołodzińska, K., Dwernicka, W., Oślizło, M., Kulbacka, J., Novickij, V., & Karłowicz-Bodalska, K. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03516-1 · Cited by 158
“Furthermore, phosphatidylserine stimulates NF-κB signaling and IL-2 secretion [17].”
Backgroundİmani, S., Farghadani, R., Roozitalab, G., Maghsoudloo, M., Emadi, M., Moradi, A., Abedi, B., & Kaboli, P. J. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03394-8 · Cited by 132
Immune Checkpoint Receptors Signaling in T Cells
Baldanzi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073529 · Cited by 80
“TIM-3 is a promiscuous receptor suggested to bind heterologous ligands, such phosphatidylserine, from apoptotic cell [69], carcin embryonic antigen cell adhesion molecule 1 (CEACAM1, [70]), the alarmin protein high mobility group B1 (HMGB1), and the carbohydrate receptor galectin-9 [71].”
BackgroundResult
Metadata
- Authors
- Smith, C. M., Li, A., Krishnamurthy, N., & Lemmon, M. A.
- Affiliations
- Yale University (US)
- Corresponding author
- Smith, Courtney M.
- Lemmon, Mark A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2021-09-14
- Volume
- 478
- Issue
- 17
- Pages
- 3331-3349
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC8454703
- OpenAlex
- W3193547547
- Cited by
- 61
- References
- 87
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 9 · 2023: 10 · 2022: 6 · 2021: 2
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochemical Journal (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R35GM122485)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TIM-3, phosphatidylserine, NF-κB signaling, IL-2 secretion, T cell receptor signaling, immunotherapy targets, Jurkat cells
- MeSH terms
- Hepatitis A Virus Cellular Receptor 2, Antibodies, Binding Sites, Humans, Interleukin-2, Ligands, Macrophages, Phosphatidylserines, Phosphorylation, Receptors, Antigen, T-Cell, T-Lymphocytes, Transfection, Signal Transduction, NF-kappa B, Apoptosis, CD28 Antigens, Jurkat Cells, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphatidylserine binding directly regulates TIM-3 function. https://app.cochat.ai/papers/10.1042/bcj20210425
- The paper
- Smith, C. M., Li, A., Krishnamurthy, N., & Lemmon, M. A. (2021). Phosphatidylserine binding directly regulates TIM-3 function. Biochemical Journal. https://doi.org/10.1042/bcj20210425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.